Evidence map›Paper›PMID 19734534›Full record

ArticleJournal of the Royal Society of Medicine2009

Pay for perfomance and the quality of diabetes management in individuals with and without co-morbid medical conditions.

Christopher Millett, Alex Bottle, Anthea Ng, Vasa Curcin, Mariam Molokhia, Sonia Saxena, Azeem Majeed

Open access · bronzeAbstract readComparative StudyMulticenter Study
In one paragraph

Article in Journal of the Royal Society of Medicine, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 7 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 7 syntheses or guidelines pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Design and effects of outcome-based payment models in healthcare: a systematic review.The European journal of health economics : HEPAC : health economics in prevention and care · 2019
    Pooled it
  4. The role of the Quality and Outcomes Framework in the care of long-term conditions: a systematic review.The British journal of general practice : the journal of the Royal College of General Practitioners · 2017
    Pooled it
  5. Effectiveness of UK provider financial incentives on quality of care: a systematic review.The British journal of general practice : the journal of the Royal College of General Practitioners · 2017
    Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Article
  10. Article
  11. The impact of concordant and discordant comorbidities on patient-assessed quality of diabetes care.Health expectations : an international journal of public participation in health care and health policy · 2015
    Article
  12. Article
  13. Pay-for-performance: impact on diabetes.Current diabetes reports · 2013
    Article
  14. Article
  15. Article
  16. Article
  17. Association of practice size and pay-for-performance incentives with the quality of diabetes management in primary care.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2011
    Article
  18. Cardiovascular multimorbidity: the effect of ethnicity on prevalence and risk factor management.The British journal of general practice : the journal of the Royal College of General Practitioners · 2011
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Christopher MillettDepartment of Primary Care & Social Medicine, Imperial College, London, UK. c.millett@imperial.ac.uk
Alex Bottle
Anthea Ng
Vasa Curcin
Mariam Molokhia
Sonia Saxena
Azeem Majeed
The London College · GBLondon School of Hygiene & Tropical Medicine · GB

Funding

Department of Health 08/1716/209Department of Health PDA/02/06/076Medical Research Council
6 · The paper itself

Abstract

objectiveTo examine the impact of the Quality and Outcomes Framework, a major pay-for-performance incentive introduced in the UK during 2004, on diabetes management in patients with and without co-morbidity.

designCohort study comparing actual achievement of treatment targets in 2004 and 2005 with that predicted by the underlying (pre-intervention) trend in diabetes patients with and without co-morbid conditions.

settingA total of 422 general practices participating in the General Practice Research Database. MAIN OUTCOMES MEASURES: Achievement of diabetes treatment targets for blood pressure (< 140/80 mm Hg), HbA1c (<or= 7.0%) and cholesterol (<or= 5 mmol/L).

resultsThe percentage of diabetes patients with co-morbidity reaching blood pressure and cholesterol targets exceeded that predicted by the underlying trend during the first two years of pay for perfomance (by 3.1% [95% CI 1.1-5.1] for BP and 4.1% [95% CI 2.2-6.0] for cholesterol among patients with >or= 5 co-morbidities in 2005). Similar improvements were evident in patients without co-morbidity, except for cholesterol control in 2004 (-0.2% [95% CI -1.7-1.4]). The percentage of patients meeting the HbA1c target in the first two years of this program was significantly lower than predicted by the underlying trend in all patients, with the greatest shortfall in patients without co-morbidity (3.8% [95% CI 2.6-5.0] lower in 2005). Patients with co-morbidity remained significantly more likely to meet treatment targets for cholesterol and HbA1c than those without after the introduction of pay for perfomance.

conclusionsDiabetes patients with co-morbid conditions appear to have benefited more from this pay-for-performance program than those without co-morbidity.

Indexed as

AdolescentAdultAgedBlood PressureCholesterolClinical CompetenceDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2Family PracticeFemaleGlycated HemoglobinHumansMaleMiddle AgedPractice Patterns, Physicians'Quality of Health CareCholesterolGlycated Hemoglobin

Identifiers

PMID19734534
PMCPMC2738769
OpenAlexW2103271936

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.